| Literature DB >> 30717391 |
Sang Hee Park1, Dong Sam Kim2, Sunggyu Kim3,4, Laura Rojas Lorz5, Eunju Choi6, Hye Yeon Lim7, Mohammad Amjad Hossain8, SeokGu Jang9, Young Im Choi10, Kyung Ja Park11, Keejung Yoon12, Jong-Hoon Kim13, Jae Youl Cho14,15.
Abstract
Loliolide is a monoterpenoid hydroxylactone present in freshwater algae that has anti-inflammatory and antiaging activity; however, its effects on ultraviolet-damaged skin have yet to be elucidated. This study investigated the antiapoptosis and wound-healing effects of loliolide using HaCaT cells (a human keratinocyte cell line). Loliolide inhibited the expression of reactive oxygen species (ROS) induced by ultraviolet radiation as well as wrinkle formation-related matrix metalloproteinase genes and increased the expression of the damage repair-related gene SIRT1. The apoptosis signaling pathway was confirmed by Western blot analysis, which showed that loliolide was able to reduce the expression of caspases 3, 8, and 9, which are related to ROS-induced apoptosis. In addition, Western blotting, reverse-transcription polymerase chain reaction (PCR), and real-time PCR analyses showed that loliolide enhanced the expression of the epidermal growth factor receptor signaling pathway (PI3K, AKT) and migration factors, such as K6, K16, and K17; keratinocyte growth factor; and inflammatory cytokines, such as interleukin (IL)-1, IL-17, and IL-22 expressed during the cellular scratching process, suggesting a putative wound-healing ability. Because of the antiapoptosis and antiscratching effects on skin of both loliolide and loliolide-rich Prasiola japonica ethanol extract, we consider the former to be an important compound used in the cosmeceutical industry.Entities:
Keywords: antiapoptosis; antioxidant activity; antiscratching effect; antiwrinkling activity
Mesh:
Substances:
Year: 2019 PMID: 30717391 PMCID: PMC6387290 DOI: 10.3390/ijms20030651
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Structure of loliolide.
Figure 2Antiapoptotic and antioxidant effects of loliolide in HaCaT cells. (a,b) Viability of HaCaT cells after being treated with loliolide alone or loliolide plus UVB, as measured by 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. (c) Reactive oxygen species (ROS) generation in H2DCFDA-stained HaCaT cells treated with UVB and loliolide was analyzed by confocal microscopy and quantified by calculation of H2DCF-DA intensity signal using ImageJ. (d) DAPI staining in HaCaT cells treated with UVB and loliolide. (e) FACS analysis in HaCaT cells treated with UVB and loliolide. (f) Western blot analysis of the expression of proteins in the apoptosis signaling pathway in UVB- and/or loliolide-treated HaCaT cells. Statistical significance was evaluated using the Kruskal–Wallis/Mann–Whitney U test. ## p < 0.05 compared with the normal group (a: Loliolide− or b, c and d: UV−/Loliolide−) and * p < 0.05 and ** p < 0.01 compared with the control group (b, c, and d: UV+/Loliolide−).
Figure 3Effect of loliolide on matrix metalloproteinase (MMP) and SIRT-1 expression in HaCaT cells. (a) Semiquantitative analysis (RT-PCR) of MMP-1, MMP-9, and SIRT-1 and (b,c) quantitative analysis of MMP-2 and MMP-3 gene expression in UVB (30 mJ/cm2)-irradiated HaCaT cells pretreated with loliolide were performed as described in the Materials and Methods section. Statistical significance was evaluated using the Kruskal–Wallis/Mann–Whitney U test. ## p < 0.05 compared with the normal group (b and c: UV−/Loliolide−) and ** p < 0.01 compared with the control group (b and c: UV+/Loliolide−).
Figure 4Effect of loliolide on cellular scratching, cell migration and inflammatory genes. (a,b) Cell migration in loliolide-pretreated scratched HaCaT cells. (c) Cell proliferation in loliolide-pretreated HaCaT cells. (d–h) RT-PCR (d) and real-time PCR (e–h) analyses of migration and inflammatory gene expression in loliolide-pretreated HaCaT cells. (i) Western blot analysis of the expression of epidermal growth factor receptor (EGFR) signaling pathway proteins in loliolide-pretreated scratched HaCaT cells. Statistical significance was evaluated using the Kruskal–Wallis/Mann–Whitney U test. ## p < 0.05 compared with the normal group (e–h: Loliolide−/Scratched−), and * p < 0.05 and ** p < 0.01 compared with the control group (b and c: Loliolide−, and f, g, and h: Loliolide−/Scratched+).
Figure 5Effects of Pj–EE on cellular scratching, cell migration, and inflammatory genes. (a) Measurement of cell viability in Pj–EE-pretreated and scratched HaCaT cells. (b,c) Cell migration in Pj–EE-pretreated scratched HaCaT cells. (d) Cell proliferation in HaCaT cells treated with Pj–EE. (e–i) RT-PCR and real-time PCR analyses of migration and inflammatory gene expression in Pj–EE-treated HaCaT cells. (j) Western blot analysis of the expression of the EGFR signaling pathway in Pj–EE-pretreated scratched HaCaT cells. Statistical significance was evaluated using the Kruskal–Wallis/Mann–Whitney U test. ## p < 0.05 compared with the normal group (f–i: Loliolide−/Scratched−), and * p < 0.05 and ** p < 0.01 compared with the control group (c and d: Pj–EE−, and f–i: Loliolide−/Scratched+).
Figure 6Antiapoptotic, antioxidant, and wound-healing effects of loliolide and Pj–EE in HaCaT keratinocytes.
Sequences of primers (human) used in semiquantitative RT-PCR.
| Name | Primer | Sequence (5’ to 3’) |
|---|---|---|
| MMP-1 | Forward | TCTGACGTTGATCCCAGAGAGCAG |
| Reverse | CAGGGTGACACCAGTGACTGCAC | |
| MMP-9 | Forward | GCCACTTGTCGGCGATAAGG |
| Reverse | CACTGTCCACCCCTCAGAGC | |
| K6 | Forward | GAGCGGCCATGAAGAAGCT |
| Reverse | TCCGCCATGCACCAACTTA | |
| K16 | Forward | CTGAGCCGCATCCTGAATGA |
| Reverse | TCGCGGGAAGAATAGGATTGG | |
| K17 | Forward | CATGCAGGCCTTGGAGATAGA |
| Reverse | CACGCAGTAGCGGTTCTCTGT | |
| SIRT-1 | Forward | CAGTGTCATGGTTCCTTTGC |
| Reverse | CACCGAGGAACTACCTGAT | |
| TNF-α | Forward | GTGACAAGCCTGTAGCCCAT |
| Reverse | CAGACTCGGCAAAGTCGAGA | |
| GAPDH | Forward | CACTCACGGCAAATTCAACGGCAC |
| Reverse | GACTCCACGACATACTCAGCAC |
Sequences of primers (human) used in quantitative real-time PCR.
| Name | Primer | Sequence (5’ to 3’) |
|---|---|---|
| MMP-2 | Forward | AAAACGGACAAAGAGTTGGCA |
| Reverse | CTGGGGCAGTCCAAAGAAC | |
| MMP-3 | Forward | TGTTAGGAGAAAGGACAGTGGTC |
| Reverse | CGTCACCTCCAATCCAAGGA | |
| IL-1 | Forward | CTTCTGGGAAACTCACGGCA |
| Reverse | AGCACACCCAGTAGTCTTGC | |
| IL-17 | Forward | CGGACTGTGATGGTCAAC |
| Reverse | CAAGGTGAGGTGGATCGGTT | |
| IL-22 | Forward | AGCCCTATATCACCAACCGC |
| Reverse | TCTCCCCAATGAGACGAACG | |
| GAPDH | Forward | GACAGTCAGCCGCATCTTCT |
| Reverse | GCGCCCAATACGACCAAATC |